5-HT3 receptor antagonists for the treatment of nausea/vomiting

被引：44
|
作者：
Smith, Howard S. [1 ]
Cox, Lorraine R. [2 ]
Smith, Eric J.
机构：
[1] Dept Anesthesiol, Albany, NY 12208 USA
[2] Albany Med Ctr Hosp, Palliat Med Serv, Albany, NY 12208 USA
来源：
ANNALS OF PALLIATIVE MEDICINE | 2012年 / 1卷 / 02期
关键词：
Nausea/Vomiting; 5-HT3; antagonists; serotonin; chemotherapy-induced nausea/vomiting; postoperative nausea/vomiting; palonostron; ondansetron;
D O I：
10.3978/j.issn.2224-5820.2012.07.07
中图分类号：
R19 [保健组织与事业（卫生事业管理）];
学科分类号：
摘要：
It is well appreciated that a number of things (e.g., various insults, chemotherapeutic agents, radiation) may lead to the release of serotonin from the enterochromaffin of the gastrointestinal tract. Released serotonin may then bind to certain 5-HT3 receptors and promote nausea/vomiting. 5-HT3 receptor antagonists may ameliorate nausea/vomiting in a number of circumstances and have been utilized as important antiemetics for multiple conditions such as chemotherapy-induced nausea/vomiting (CINV), radiation-induced emesis (RIS), and postoperative nausea/vomiting (PONV).
引用
收藏
页码：115 / 120
页数：6
相关论文
共 50 条
  • [1] 5-HT3 ANTAGONISTS IN POSTOPERATIVE NAUSEA AND VOMITING
    RUSSELL, D
    KENNY, GNC
    BRITISH JOURNAL OF ANAESTHESIA, 1992, 69 (07) : S63 - S68
  • [2] Comparative Pharmacology and Guide to the Use of the Serotonin 5-HT3 Receptor Antagonists for Postoperative Nausea and Vomiting
    Anthony L. Kovac
    Drugs, 2016, 76 : 1719 - 1735
  • [3] TREATMENT OF POSTOPERATIVE NAUSEA AND VOMITING AFTER OUTPATIENT SURGERY WITH THE 5-HT3 ANTAGONIST ONDANSETRON
    SCUDERI, P
    WETCHLER, B
    SUNG, YF
    MINGUS, M
    DUPEN, S
    CLAYBON, L
    LESLIE, J
    TALKE, P
    APFELBAUM, J
    SHARIFIAZAD, S
    WILLIAMS, MF
    ANESTHESIOLOGY, 1993, 78 (01) : 15 - 20
  • [4] Impact of 5-HT3 receptor antagonists on chemotherapy-induced nausea and vomiting: a retrospective cohort study
    Lin, Swu-Jane
    Hatoum, Hind T.
    Buchner, Deborah
    Cox, David
    Balu, Sanjeev
    BMC HEALTH SERVICES RESEARCH, 2012, 12
  • [5] Efficacy of 5-HT3 receptor antagonists in radiotherapy-induced nausea and vomiting:: A quantitative systematic review
    Tramer, MR
    Reynolds, DJM
    Stoner, NS
    Moore, RA
    McQuay, HJ
    EUROPEAN JOURNAL OF CANCER, 1998, 34 (12) : 1836 - 1844
  • [6] Impact of 5-HT3 receptor antagonists on chemotherapy-induced nausea and vomiting: a retrospective cohort study
    Swu-Jane Lin
    Hind T Hatoum
    Deborah Buchner
    David Cox
    Sanjeev Balu
    BMC Health Services Research, 12
  • [7] 5-HT3-receptor antagonists in the management of nausea and vomiting in cancer and cancer treatment
    Aapro, M
    ONCOLOGY, 2005, 69 (02) : 97 - 109
  • [8] 5-HT3 receptor antagonistsvs traditional agents for the prophylaxis of postoperative nausea and vomiting
    Peter S. Loewen
    Carlo A. Marra
    Peter J. Zed
    Canadian Journal of Anesthesia, 2000, 47 : 1008 - 1018
  • [9] Efficacy of 5-HT3 receptor antagonists (ondansetron) vs dopamine receptor antagonists (droperidol) for preventing postoperative nausea, vomiting and headache: a meta-analysis
    Chen, Xiaoyun
    Qin, Yinying
    Li, Siying
    Lei, Heshou
    Wu, Xiaoyun
    Shu, LiPei
    PTERIDINES, 2019, 30 (01) : 146 - 152
  • [10] 5-HT3 RECEPTORS AND THE THERAPEUTIC POTENTIAL OF 5-HT3 RECEPTOR ANTAGONISTS
    TYERS, MB
    THERAPIE, 1991, 46 (06): : 431 - 435
12345